PTGS2 and inflammatory bowel disease: Related studies have shown that nobiletin can protect the intestinal epithelium barrier by reducing inflammatory cytokines and can reduce duodenal retraction to treat inflammatory bowel disease by inhibiting tumor necrosis factor-α (TNF-α) and the expression of COX-2.